Search Results (1,111)

Multifunctional drugs represent an emerging strategy for treating complex skin disorders and melanoma. A series of benzothiazole-based hybrids incorporating gallic and syringic acid moieties was synthesized and evaluated as multifunctional agents for skin-related applications. Six hydrazone (GAHYDR1–3) and acyl-hydrazone (GACIN1–3) derivatives were obtained and fully characterized. Hydroxylated compounds showed the strongest antioxidant activity, with GAHYDR1 and GACIN1 displaying low DPPH IC₅₀ values and high FRAP reducing power. UV–Vis studies revealed strong UVA–UVB absorption, with molar extinction coefficients comparable to or exceeding those of PBSA. Photoprotective evaluation showed SPF values up to 10.09 (GACIN2) and broad-spectrum behavior for selected derivatives. Antioxidant activity remained substantially stable over 3 months in solution. Antiproliferative assays against Colo38, A375, and HaCaT cell lines indicated generally low cytotoxicity toward non-tumor cells. Notably, GAHYDR3 exhibited selective activity against A375 melanoma cells (IC₅₀ = 8.75 µM; SI = 8.12). Overall, phenolic substitution emerged as a key determinant of biological activity, highlighting hydroxylated benzothiazole hybrids as promising antioxidant and photoprotective agents, with GAHYDR3 representing a potential lead for anti-melanoma development. Full article

Celastrol, one of the top five traditional natural products with high potential for modern drug development, exerts potent broad-spectrum biological activities, yet its poor aqueous solubility, low bioavailability, potential toxicity, and limited selectivity severely compromise its drug-likeness. Advanced drug delivery strategies, mainly including multifunctional polymer/lipid/protein-based organic nanoparticles, metal/silica-based inorganic nanoparticles, vesicles represented by liposomes, and nanoemulsions, are expected to overcome these druggability hurdles of celastrol via oral, transdermal or intravenous administration. This review summarizes recent progress in a series of celastrol formulations, including novel dosage forms and delivery routes accompanied with consequential pharmacological effects and mechanisms of action, which have the potential to bring about better druggability conducive to future medical treatment. Full article

The increasing prevalence of antimicrobial resistance (AMR) has promoted the development of advanced biomaterials capable of overcoming the limitations of conventional antibiotics. In this context, metal nanoparticle hybrid hydrogels (MNHHs) have emerged as multifunctional platforms that integrate the high water-retention capacity and biocompatibility of hydrogels with the antimicrobial properties of metallic nanoparticles (MNPs). This review critically analyzes recent advances in the design, physicochemical properties, antimicrobial mechanisms, and biomedical applications of these systems. Current evidence demonstrates that MNHHs can achieve antimicrobial efficiencies above 98–99%, with minimum inhibitory concentrations as low as 0.78 µg mL⁻¹ and inhibition zones of up to 25 mm against clinically relevant pathogens. Furthermore, the incorporation of MNPs significantly improves the mechanical properties of hydrogels and enables controlled and sustained metal ion release for periods of up to 14 days. Despite these promising results, important challenges remain regarding cytotoxicity, release control, the lack of experimental standardization, and the limited understanding of long-term biological effects. Overall, MNHHs represent a promising strategy for infection control, regenerative medicine, and controlled drug delivery; however, their clinical translation still requires the development of reproducible, safe, scalable, and highly biocompatible systems. Full article

The rapid emergence of antimicrobial resistance has intensified the need for advanced therapeutic platforms capable of improving the efficacy, stability, and targeted delivery of antimicrobial agents. Electrospun nanofibers have emerged as highly promising materials for biomedical applications due to their large surface area, high porosity, tunable morphology, and ability to incorporate a broad range of bioactive compounds. This review provides a comprehensive overview of the design, fabrication, and biomedical applications of electrospun bioactive nanofibers functionalized with antimicrobial drugs. It presents the main nanofiber fabrication techniques, with particular emphasis on electrospinning and the influence of solution, process, and environmental parameters on fiber morphology and drug-loading efficiency. Natural, synthetic, and hybrid polymer systems commonly employed in electrospun antimicrobial nanofibers are analyzed in relation to their physicochemical properties, biocompatibility, and therapeutic performance. In addition, the review highlights different drug incorporation strategies, including encapsulation, immobilization, and surface coating, as well as the mechanisms of action of antimicrobial agents. Recent advances in nanotechnology-based antimicrobial systems and their role in overcoming analytical, biopharmaceutical, and drug-delivery limitations are also examined. Furthermore, the review addresses current challenges related to scalability, reproducibility, stability, and clinical translation of electrospun nanofibers. Finally, future perspectives focusing on multifunctional, stimuli-responsive, and personalized antimicrobial nanofiber systems are discussed as promising directions for combating bacterial infections and reducing the global burden of antimicrobial resistance. Full article

Diabetic chronic wounds are often accompanied by excessive wound exudate maceration, which prolongs the inflammatory phase and increases the risk of infection. Such a complex wound microenvironment imposes more stringent requirements on multifunctional wound dressings. A multifunctional Cur Janus nanofibrous dressing is developed by integrating an electrospun poly(ε-caprolactone)/gelatin hydrophilic layer with a curcumin (Cur)-loaded PCL hydrophobic layer. Janus structure with asymmetric wettability, which exhibited unidirectional liquid transport properties both in vitro and in vivo. Its unique structure also makes it possible to carry both hydrophilic and hydrophobic drugs at the same time. The incorporation of curcumin endows the dressing with antibacterial and antioxidant functionalities, offering the potential to modulate the inflammatory microenvironment of diabetic chronic wounds. Furthermore, the wound healing ability and anti-inflammatory effects of Cur Janus nanofibers were evaluated in a diabetic mouse model. The results showed that Cur Janus nanofibers significantly reduced wound area, increased the proportion of pro-healing M2 macrophages, shortened the inflammatory phase, and ultimately accelerated diabetic wound healing. This work provides a multifunctional and scalable platform for advanced wound dressing design. Its excellent antibacterial, antioxidant (ROS scavenging) and anti-inflammatory (macrophage phenotype M1 to M2) properties, combined with the unidirectional fluid transport and dual-release potential of hydrophilic and hydrophobic drugs, demonstrate broad prospects in the management of diabetic wounds. Full article

Polyhydroxyalkanoates (PHAs) are bio-based, biodegradable polyesters increasingly explored as sustainable biomaterials for regenerative medicine. This review summarizes recent advances in PHA-based bone substitute materials, highlighting their properties, fabrication methods, and biological performance. PHAs combine biocompatibility, tunable mechanical behavior, and degradation into non-toxic metabolites, while copolymerization and monomer selection modulate the stiffness, crystallinity, and resorption rate. Processing techniques such as solvent casting, electrospinning, and additive manufacturing allow the production of porous architectures that mimic bone extracellular matrix. Electrospinning is particularly suitable for nanoscale fibrous matrices, whereas 3D printing enables patient-specific scaffolds with controlled geometry and interconnected porosity. Scaffold performance can be further improved through the incorporation of osteoconductive fillers, including hydroxyapatite, β-tricalcium phosphate, bioactive glasses, graphene oxide, and carbon nanotubes, as well as through drug-delivery and pro-angiogenic functionalization. In vitro and in vivo studies consistently report favorable cytocompatibility, enhanced osteogenic differentiation, vascularization, and effective repair of bone defects in animal models. However, clinical translation remains limited by production costs, variability in polymer quality, thermal processing constraints, and regulatory challenges. Future progress will rely on more efficient biosynthesis, medical-grade purification, multifunctional scaffold design, and stronger collaboration between academia, industry, and clinicians to unlock the full potential of PHAs in regenerative bone therapies. Full article

The production of inexpensive, effective sorbents from natural materials for the purification of water bodies and/or soils is a pressing problem. Therefore, the purpose of this manuscript is to summarize current approaches to the use of brown coal (lignite) and its processing products (humic acids, HAs) as sorbents for the purification of aqueous and soil environments from heavy metal ions and other pollutants. Modification of lignite (chemical, biological, physicochemical) or the creation of lignite–mineral composites significantly increases its sorption capacity and stability: after modification, the sorption capacity can reach more than 85 mg of heavy metals per g of sorbent, which is only 3 times lower than that of specialized, expensive sorbents. Also, good results are achieved in the case of sorption of water-soluble organic drugs, dyes, etc. Humic acids obtained from brown coal have better selectivity and efficiency than the original lignite, and slightly worse than the modified one, in terms of removing cadmium, lead, copper, and other toxic elements; and also, can complex with organic xenobiotics. Current research trends indicate growing interest in multifunctional composite sorbents, environmentally friendly extraction technologies, and the development of materials with enhanced selectivity and regeneration ability. Future studies should focus on improving the understanding of sorption mechanisms, optimizing modification strategies, scaling up lignite-based technologies for practical environmental applications, and developing waste-free technologies to produce sorbents from lignite. Full article

Radiolabelled nanoparticles are increasingly investigated as multifunctional platforms for cancer imaging, biodistribution tracking, dosimetry, and radionuclide-based therapy. This review focuses on three representative inorganic nanoplatforms: zinc oxide (ZnO), iron oxide-based, and gold (Au) nanoparticles. These systems were selected because they combine distinct physicochemical properties with versatile surface engineering and radiolabelling strategies. ZnO nanoparticles offer pH-responsive behaviour and drug-delivery potential; iron oxide-based nanoparticles provide magnetic functionality, Magnetic resonance imaging (MRI) compatibility, and opportunities for magnetic hyperthermia or local nanobrachytherapy; and Au nanoparticles enable stable surface functionalization, radiometal chelation, radiosensitisation, photothermal effects, and alpha or beta-emitter-based local therapy. The review critically discusses synthesis and surface-modification methods, chelator-mediated and chelator-free radiolabelling, coating-assisted and anchoring-mediated strategies, and the influence of these factors on radiochemical stability, biodistribution, tumour uptake, therapeutic response, toxicity, and clearance. A function-based comparison of the reviewed studies highlights that many systems demonstrate efficient radiolabelling and imaging capability, whereas fewer provide direct in vivo therapeutic efficacy, long-term toxicity, or metabolic clearance data. Overall, radiolabelled ZnO, iron oxide-based, and Au nanoparticles show strong potential for cancer theranostics, tumour-to-organ distribution, therapeutic benefit, and safety. Full article

Raw lacquer, a natural polymer derived from the bast of lacquer trees (Toxicodendron vernicifluum), is renowned as the “King of Coatings” due to its exceptional film-forming properties, abrasion resistance, corrosion resistance, and biocompatibility. However, its inherent limitations—including stringent drying conditions, slow curing rates, deep coloration, and difficult application—have severely restricted its modernization and widespread adoption. This review systematically summarizes recent research advances in the modification and application of raw lacquer, focusing on four major modification strategies: (1) Nanocomposite modification—incorporating functional nanofillers such as Al₂O₃, cellulose nanofibrils (CNF), polydopamine (PDA) melanin-like nanoparticles, and SiO₂ to significantly enhance film hardness, compactness, UV-aging resistance, and drying kinetics. (2) Chemical structure modification—employing molecular design strategies including aminoanthraquinone grafting, tung oil blending, water-based emulsification, and terpene/allyl group functionalization to improve hydrophobicity, flexibility, fast-drying properties, and achieve dual photo/oxygen curing. (3) Biomass synergistic composites—utilizing natural polymers such as chitosan and lignin, along with bio-inspired adhesion mechanisms (e.g., PDA), to confer advanced functionalities including antibacterial and antifouling properties. (4) Curing behavior regulation—precisely controlling drying kinetics through inorganic salt ion microenvironment engineering, nonionic surfactants, and salicylaldehyde Schiff base-based driers. Building upon these foundations, this review further expands on the emerging high-value applications of modified lacquer in preventive conservation of cultural heritage, advanced functional coatings (anti-corrosion, super-hydrophobicity, flame retardancy), biomedical materials (hemostasis, antibacterial activity, drug-controlled release, water treatment adsorption), and intelligent responsive flexible electronics. Finally, addressing challenges including weak fundamental research, bottlenecks in green industrialization, and lack of standardization, future development directions are proposed encompassing interdisciplinary innovation, sustainable modification strategies, integration of multifunctional intelligent systems, and big data-driven research paradigms, aiming to provide theoretical guidance and technical references for the high-value utilization and modernization of lacquer resources. Full article

The global transition from petrochemical to sustainable bio-based plastics has been strongly supported by electrospinning (ES), a versatile nanotechnology enabling the fabrication of ultrathin fibers with multifunctional properties. The solution ES process alongside the uniform fibers, a characteristic “beads-on-string” morphology, consisting of alternating cylindrical and spindle-like segments, is frequently observed. Once considered undesirable, these structures are now recognized as functional fibrous architectures with enhanced properties. This work explores the valorization of beaded fibers through combined experimental characterization and modeling, aiming to evaluate the impact of beading on drug diffusion and delivery performance. Poly(3-hydroxybutyrate) (PHB) was selected as the model biopolyester and dipyridamole (DPD) as the model drug. Ultrathin fibers were fabricated using the laboratory electrospinning device, EFV-1 (ICP, Moscow, Russia). The distance between the capillary nozzle and the anodic collector was set to 180 mm, with the capillary tip radius equal to 0.35 mm, and applied voltage between the electrodes was kept constant at 18 kV. Drug release profiles were obtained by simulating DPD diffusion in ellipsoidal (beads) and cylindrical fiber domains. Ultrathin fibers were fabricated by solution electrospinning under environmental conditions (at ambient temperature, 50% relative humidity). Morphology was analyzed via SEM, thermal properties via DSC, and structure via FTIR spectroscopy at different temperatures, including the melting point (~170 °C). Drug release kinetics were monitored using a UV-Vis spectroscopy. The impact of DPD diffusion within the ellipsoidal and cylindrical constituents of polymer filaments was considered to modulate release profiles for the development of innovative pharmaceutical platforms. Diffusion controlled drug release was computationally modeled using a specially designed simulation program, in good agreement with experimental data. The results demonstrate that morphological parameters significantly affect diffusion and release kinetics. The controlled exploitation of bead-on-string architectures may enable the design of electrospun materials with tunable absorption of pollutant filtration, mechanical performance, and flexibility in drug release profiles, for sustainable biopolymers like PHB. Full article

Achieving precise control over anticancer drug release remains one of the key challenges in modern pharmaceutical development, as it directly determines therapeutic efficacy, systemic toxicity, and patient outcomes. This review critically evaluates recent advances in three major formulation strategies: polymeric solid dispersions, cyclodextrin-based inclusion complexes, and metal–organic frameworks (MOFs), with a particular focus on their capacity to tailor anticancer drug release. Over the past decade, polymeric solid dispersions and cyclodextrin-based carriers have played a central role in improving the dissolution and bioavailability of poorly water-soluble anticancer agents, while also enabling modified release profiles through rational formulation design. Increasing structural complexity, including ternary systems and supramolecular assemblies, reflects a shift toward more controllable delivery platforms. In recent years, MOFs have emerged as highly adaptable porous materials capable of supporting controlled and stimuli-responsive release. The integration of imaging agents, magnetic components, and photothermal functionalities has further enabled the design of multifunctional and theranostic platforms. Taken together, these technologies reflect a shift from conventional solubility enhancement toward structurally engineered systems designed to achieve predictable and controlled drug release. Continued advances in material design and formulation strategies are expected to further refine release kinetics and support the development of next-generation anticancer therapies aligned with the growing demand for precision medicine. Full article

The photothermal conversion capability of polydopamine (PDA) was exploited to load the anticancer drug doxorubicin (DOX) onto its surface via π-π stacking and hydrogen-bond interactions, yielding a PDA-DOX complex. In this study, biocompatible poly-L-lactic acid (PLLA) was employed as a shell material to fabricate multifunctional PLLA composite PDA-DOX (PLLA@PDA-DOX) nanobubbles with integrated functions of ultrasound imaging, photothermal therapy, and chemotherapy. The fabricated nanobubbles exhibited a uniform mean diameter of 489.30 ± 6.96 nm with a Polydispersity index (PDI) of 0.226 ± 0.01 and a DOX loading efficiency of 3.27%. Acute toxicity evaluation in mice revealed that the maximum tolerated dose of PLLA@PDA-DOX nanobubbles was markedly higher than the clinical equivalent dose, showing no detectable toxicity or allergic reactions. Under near-infrared (NIR) laser irradiation, the inhibition rate of HCCLM3 cells increased from 50.1% to 64.45%, indicating enhanced therapeutic efficacy through the combined effects of photothermal therapy and chemotherapy. Moreover, compared with the free DOX group, the survival rate of LX-2 cells in the composite nanobubble group significantly increased from 18.9 ± 1.56% to 68.8 ± 3.08%, suggesting that the PLLA@PDA-DOX nanobubbles effectively reduced the direct cytotoxicity of DOX by preventing its immediate contact with cells. Collectively, the results confirm that PLLA@PDA-DOX nanobubbles possess excellent biocompatibility, robust ultrasound imaging performance, and enhanced antitumor efficacy under NIR irradiation. This multifunctional nanosystem demonstrates promising potential as an integrated platform for simultaneous cancer diagnosis and therapy. Full article

Plenty of nano-antimicrobial materials have been developed successively, aiming to address severe clinical challenges such as wound healing disorders and high postoperative mortality rates caused by drug-resistant bacterial infections. However, their reliance on external stimuli (light, thermal energy, or exogenous H₂O₂ addition) for bactericidal activation severely hampers clinical translation from bench to bedside. Herein, we report an engineered Cu/CeO₂ nanoplatelet (NP) system that functions as a stimulus-independent, time-dependent nano-antibiotic against methicillin-resistant Staphylococcus aureus (MRSA), while also exhibiting broad-spectrum antibacterial activity. In a skin wound model infected with MRSA, topical application of only 1 μg/mL achieved near-complete wound closure within 10 days. The satisfactory therapeutic effect is concluded: (1) Cu/CeO₂ NPs continuously release Cu²⁺, which damages the integrity of bacterial cell membranes and achieves efficient sterilization. (2) The antioxidant stress capacity, peroxidase, and catalase-like activity effectively alleviate oxidative stress and hypoxia conditions in the infected microenvironment, and synergistically exert multiple biological effects such as anti-inflammatory, promoting collagen deposition and the formation of new blood vessels. This study not only provides a feasible pathway for the clinical application of antibacterial nano-materials, but also offers theoretical support and practical examples for the rational design of multifunctional nano-antibiotics. Full article

This investigation addressed challenges in the delivery of poorly soluble drugs, and the colloidal processing of polymer–ceramic composites by fabrication of advanced supramolecular hydrogels. Polygalacturonic acid (PGA) polymer and 18β-glycyrrhetinic acid (GA) drug, both characterized by poor aqueous solubility, were selected as model building blocks for supramolecular hydrogels. Meglumine (MG) served as a multifunctional component in the gels, acting as a building block as well as an alkalizing and solubilizing agent for PGA and GA. Investigations revealed gel formation mechanisms, which were based on the electrostatic interactions of deprotonated anionic carboxylic groups of PGA and GA with protonated amino groups of MG and the hydrogen bonding of PGA polymer and GA molecules. The feasibility of the fabrication of PGA-MG and GA-MG gels opened an avenue for the fabrication of PGA-GA-MG gels. The composite gels provided a platform for drug delivery, and the kinetics of drug release from the composite gels containing MG excipient were investigated. Composite gels were obtained from colloidal dispersions, containing bioceramics, such as hydroxyapatite, silica, and titania, and bioglass in the PGA solutions in the presence of MG. The results of this investigation pave the way for the fabrication of novel supramolecular and composite gels loaded with various functional materials. Full article

The shortage of effective chemotherapeutic agents poses a significant challenge to the global public health system. Cancer is among the leading diseases affecting the human population worldwide. Issues such as drug resistance, toxicity, lack of specificity, poor bioavailability and water solubility, and severe side effects reduce the effectiveness of many existing anticancer drugs. As a result, there is growing interest in discovering a new generation of therapeutic agents to overcome these limitations. Phenolic acids, including ferulic and caffeic acids, are cinnamic acid derivatives with numerous biological effects, including anti-inflammatory, antibacterial, antifungal, antioxidant, antiviral, cytotoxic, and antiproliferative effects. In recent years, drug repurposing and hybridization strategies have emerged as attractive approaches in medicinal chemistry because they may reduce both the cost and time associated with conventional drug discovery. As a result, several researchers have combined ferulic acid and caffeic acid scaffolds with different pharmacophores to generate hybrid compounds with enhanced anticancer potential. This review summarizes recent in vitro and in silico studies published between 2022 and 2025 on ferulic and caffeic acid hybrid compounds that exhibit cytotoxic and antiproliferative effects. Furthermore, the review discusses structure–activity relationship trends, synthetic approaches, and structural modifications associated with improved biological activity. Collectively, the findings highlight the significant potential of ferulic acid and caffeic acid scaffolds in the development of multifunctional anticancer agents. Full article